Folgen
Lennard Bohlender
Lennard Bohlender
AG Reski, Plant Biotechnology, University of Freiburg
Bestätigte E-Mail-Adresse bei biologie.uni-freiburg.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Moss-produced, glycosylation-optimized human factor H for therapeutic application in complement disorders
S Michelfelder, J Parsons, LL Bohlender, SNW Hoernstein, ...
Journal of the American Society of Nephrology 28 (5), 1462-1474, 2017
432017
Recombinant production of MFHR1, a novel synthetic multitarget complement inhibitor, in moss bioreactors
O Top, J Parsons, LL Bohlender, S Michelfelder, P Kopp, ...
Frontiers in Plant Science 10, 260, 2019
212019
Stable protein sialylation in physcomitrella
LL Bohlender, J Parsons, SNW Hoernstein, C Rempfer, N Ruiz-Molina, ...
Frontiers in Plant Science 11, 610032, 2020
202020
A synthetic protein as efficient multitarget regulator against complement over-activation
N Ruiz-Molina, J Parsons, M Müller, SNW Hoernstein, LL Bohlender, ...
Communications Biology 5, 152, 2022
82022
Unexpected arabinosylation after humanization of plant protein N-glycosylation
LL Bohlender, J Parsons, SNW Hoernstein, N Bangert, ...
Frontiers in Bioengineering and Biotechnology 10, 838365, 2022
82022
Treatment of experimental C3 Glomerulopathy by human complement factor H produced in glycosylation-optimized Physcomitrella patens
K Häffner, J Parsons, LL Bohlender, S Hoernstein, H Niederkrüger, ...
Molecular Immunology, 120, 2017
52017
Stable N-Glycan Sialylation in Physcomitrella
LLB Juliana Parsons, Sebastian N.W. Hoernstein, Christine Rempfer, Natalia ...
4th ISPMF conference, 60-61, 2021
2021
Moss-made complement therapeutics
A Schaaf, T Tschogonov, S Michelfelder, N Krieghoff, J Koch, A Busch, ...
Molecular Immunology 102, 209, 2018
2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–8